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Abstract
Immune challenge by bacterial lipopolysaccharide (LPS) causes short-term behavioral changes indicative of depression. The
present study sought to explore whether LPS is able to induce long-term changes in depression-related behavior and
whether such an effect depends on mouse strain and social context. LPS (0.83 mg/kg) or vehicle was administered
intraperitoneally to female CD1 and C57BL/6 mice that were housed singly or in groups of 4. Depression-like behavior was
assessed with the forced swim test (FST) 1 and 28 days post-treatment. Group-housed CD1 mice exhibited depression-like
behavior 1 day post-LPS, an effect that leveled off during the subsequent 28 days, while the behavior of singly housed CD1
mice was little affected. In contrast, singly housed C57BL/6 mice responded to LPS with an increase in depression-like
behavior that was maintained for 4 weeks post-treatment and confirmed by the sucrose preference test. Group-housed
C57BL/6 mice likewise displayed an increased depression-like behavior 4 weeks post-treatment. The behavioral changes
induced by LPS in C57BL/6 mice were associated with a particularly pronounced rise of interleukin-6 in blood plasma within
1 day post-treatment and with changes in the dynamics of the corticosterone response to the FST. The current data
demonstrate that immune challenge with LPS is able to induce prolonged depression-like behavior, an effect that depends
on genetic background (strain). The discovery of an experimental model of long-term depression-like behavior after acute
immune challenge is of relevance to the analysis of the epigenetic and pathophysiologic mechanisms of immune system-
related affective disorders.
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Introduction
Experimental and clinical evidence indicates that activation of
the immune system contributes to the pathogenesis of mood
disorders [1–6]. Patients with major depression have frequently
been observed to present with elevated levels of proinflammatory
cytokines in blood plasma and cerebrospinal fluid [4]. There is
extensive comorbidity of major depression with medical conditions
involving inflammation and an increased expression of cytokines,
and the therapeutic use of cytokines such as interferons is known to
induce a depression-like syndrome in a sizeable proportion of
patients [5]. These lines of clinical evidence are complemented by
a plethora of animal studies. Both peripheral induction of
cytokines by infection [6–9] or cancer [10] and intracerebral
administration of cytokines to rodents evoke depression-like
symptoms which are abrogated by cytokine antagonists or cytokine
synthesis blockers.
Peripheral induction of cytokines by systemic administration of
bacterial lipopolysaccharide (LPS) at doses that are too low to
evoke a shock-like condition is known to induce a behavioral
syndrome that includes traits of depression and follows a distinct
time course [3,6,11]. Initially, a response termed ‘‘sickness
behavior’’ is prevailing, which includes fever, anorexia, reduction
of locomotion and a decrease in social interaction. Once the
sickness behavior in terms of anorexia and sedation is over,
behavioral symptoms indicative of depression such as anhedonia
and passive stress coping are observed 24–48 h post-treatment
[12,13]. When neuropeptide Y receptors of subtype Y2 or Y4 have
been knocked out, depression-like behavior is seen even 4 weeks
after a single injection of low-dose LPS [14]. This observation led
us to hypothesize that, depending on genetic background (mouse
strain) and social context (single versus group housing), intraper-
itoneal (IP) injection of LPS is able to induce long-term depression-
like behavior. We addressed this hypothesis by studying the
behavioral effect of LPS with the forced swim test (FST), a
measure of behavioral despair [15], and the sucrose preference
test, a measure of depression-related anhedonia [12]. These tests
were carried out 1 day and 4 weeks post-LPS treatment.
Two strains of mice, outbred CD1 mice and inbred C57BL/6
mice, were compared with each other. CD1 mice were selected
because short-term behavioral changes indicative of a state of
depression following LPS treatment have extensively been studied
in this mouse strain [12]. C57BL/6 mice were chosen because the
Y2 and Y4 receptor knockout mice that exhibit long-term
depression-like behavior following LPS treatment have a 50%
C57BL/6 background [14]. In addition, C57BL/6 mice harbor a
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coding variants, which have implications on serotonin transporter
function [16]. The experiments were carried out with female mice,
given that affective disorders are more prevalent in women than in
men [17] and there is a need to overcome the sex bias that is
present in the neurosciences [18].
Apart from genetic background, psychosocial context may be
another factor relevant to the manifestation of mood disturbances
due to immune challenge [19–22]. Psychosocial stress is able to
evoke cerebral expression of cytokines [5,23,24], and prolonged
separation of mice enhances the LPS-evoked sickness behavior
[22]. Since social isolation of mice is also able to enhance
depression-like behavior [25], we used this experimental paradigm
to address the question whether social context modifies the effect
of LPS to induce long-term changes in affective behavior. Thus,
female CD1 and C57BL/6 mice were either kept in groups of 4 or
housed singly throughout the course of the experiments.
LPS-evoked peripheral immune challenge alters brain functions
by a neural and an endocrine route [6,11]. In addition, LPS and
proinflammatory cytokines are able to stimulate the hypothalamic-
pituitary-adrenal (HPA) axis as revealed by a rise of circulating
glucocorticoid levels [4–6,22]. For this reason, plasma levels of
interleukin-6 and corticosterone were monitored to examine
whether any behavioral changes are correlated with these factors.
Materials and Methods
Experimental animals
The study was carried out with age-matched, adult, 4–6 month
old, female mice of the outbred strain CD1 and the inbred strain
C57BL/6, which were obtained from Charles River Laboratories
(Sulzfeld, Germany). The animals were kept in groups of 4 in cages
of size IIL (length6width6height=26 cm620.5 cm614 cm) in
the institutional animal house in which the temperature (set point
22uC), relative air humidity (set point 50%) and light conditions
(lights on at 6:00 h, lights off at 18:00 h, maximal intensity
150 lux) were tightly controlled. Tap water and standard
laboratory chow were provided ad libitum throughout the study.
Ethics statement
The experimental procedures and number of animals used in
this study were approved by an ethical committee at the Federal
Ministry of Science and Research of the Republic of Austria and
conducted according to the Directive of the European Commu-
nities Council of 24 November 1986 (86/609/EEC). The
experiments were designed in such a way that the number of
animals used and their suffering was minimized.
Administration of lipopolysaccharide (LPS)
LPS extracted from E. coli 0127:B8 (purified by gel-filtration
chromatography, catalogue number L3137, Sigma-Aldrich,
Vienna, Austria) was dissolved in pyrogen-free sterile saline
(0.9% NaCl) at a concentration of 1 mg/ml. This stock solution
was diluted with pyrogen-free sterile saline to yield an injection
solution of 0.083 mg/ml LPS, which was injected IP at a volume
of 0.01 ml/g, equivalent to a dose of 0.83 mg/kg LPS [12,14].
Pyrogen-free sterile saline injected at the same volume was used as
vehicle control.
Experimental groups and time lines
The experiments were started after the animals had become
familiar with the institutional animal house over the course of at
least 3 weeks. Prior to the behavioral tests, the mice were allowed
to adapt to the test room (set points 22uC and 50% relative air
humidity, lights on at 6:00 h, lights off at 18:00 h, maximal light
intensity 100 lux) for at least two days.
Two different protocols were used (Figure 1). In protocol 1, the
effect of IP injected vehicle and LPS on depression-like behavior in
the FST was assessed 1 and 28 days post-injection. For this
purpose a total of 64 CD1 and 64 C57BL/6 mice was employed.
The animals of each strain were allocated to 8 experimental
groups (Figure 1), each group comprising 8 mice. The animals
were either kept in sets of 4 animals per cage (group housing) or
housed individually (single housing). The single housing protocol
was started 7 days before IP injection of vehicle or LPS (Figure 1).
After the FST, the mice were instantly returned to their home
cage, and care was taken not to change cage mates during the
course of the experiment. Thirty minutes after the start of the FST,
trunk blood was collected for determination of the circulating
levels of corticosterone and interleukin-6.
In protocol 2, the effect of vehicle and LPS on the sucrose
preference of 14 singly housed C57BL/6 mice was assessed during
days 21–4 and days 26–27 post-treatment (Figure 1). The single
housing protocol was started 7 days before IP injection of vehicle
or LPS. The animals were offered the choice to drink from two
bottles, one filled with tap water and the other filled with 1%
sucrose in tap water. The daily intake of tap water and sucrose
solution was estimated by weighing the bottles every day.
Forced swim test (FST)
Each mouse was placed individually in a glass cylinder
(diameter: 16 cm, height: 23 cm) containing tap water at 25uC.
The water was 16 cm deep, which prevented the mice from
touching the bottom of the beaker with their paws or the tail.
Three categories of behavioral activity (climbing, swimming, and
immobility) during the 6 min test session [14,26] were scored by a
trained observer. The time each mouse spent climbing, swimming
and floating (immobile) during the FST was recorded and
expressed as a percentage of the test duration. Mice were
considered immobile when they floated passively in the water,
performing only movements that enabled them to keep their heads
above the water level [15]. After the FST, the mice were placed for
6 min under a warming lamp and then returned to their home
cage.
Sucrose preference
The animals were offered the choice to drink from two bottles,
one filled with tap water and the other filled with 1% sucrose in
tap water. The daily intake of tap water and sucrose solution was
estimated by weighing the bottles every day between 8:30 h and
9:00 h. After they had been weighed, the bottles were cleaned and
refilled every day. In addition, the relative position of the two
bottles in the cage lid was changed every day.
Circulating corticosterone
Thirty minutes after the FST, between 11:00 h and 13:00 h,
mice were deeply anesthetized with pentobarbital (150 mg/kg IP)
before they were decapitated. Within 2 min after the injection of
anesthetic, trunk blood was collected into vials coated with
ethylenediamine tetraacetate (Greiner, Kremsmu ¨nster, Austria)
kept on ice. Following centrifugation for 10 min at 4uC and
12006g, blood plasma was collected and stored at 270uC until
assay. The plasma levels of corticosterone were determined with
an enzyme immunoassay kit (Assay Designs, Ann Arbor,
Michigan, USA). According to the manufacturer’s specifications,
the sensitivity of the assay is 27 pg/ml, and the intra- and inter-
assay coefficient of variation amounts to 7.7 and 9.7%,
respectively.
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A part of the blood plasma collected for determination of
corticosterone was used for the assay of circulating interleukin-6.
The plasma levels of interleukin-6 were determined with an
enzyme immunoassay kit (Fluorokine MAP Mouse IL-6 Kit, R&D
Systems, Minneapolis, Minnesota, USA). According to the
manufacturer’s specifications, the sensitivity of the assay is
1.1 pg/ml, and the intra- and inter-assay coefficient of variation
amounts to 4.0 and 7.4%, respectively.
Statistics
Statistical evaluation of the results was made with SPSS 16.0
(SPSS Inc., Chicago, Illinois, USA). In general, the data were
analyzed by two-way analysis of variance (ANOVA), in some cases
for repeated measurements. The homogeneity of variances was
assessed with the Levene test. In case of sphericity violations the
Greenhouse-Geisser correction was applied. Post-ANOVA anal-
ysis of group differences was performed with the Tukey HSD
(honestly significant difference) test, when the variances were
homogeneous, and with the Games-Howell test, when the
variances were unequal. Student’s t test was used when only two
data groups were compared with each other. Some experiments
were analyzed by planned comparisons with the Mann-Whitney test
[27]. In view of the exploratory nature of the study, probability
values P#0.1 [27–29] were regarded as statistically significant. All
data are presented as means6SEM, n referring to the number of
mice in each group.
Results
LPS reduced body weight 1 day post-treatment
The body weight of the animals was recorded immediately
before (day 0) and 1 day after IP injection of vehicle or LPS. The
body weight before treatment did not differ between the
experimental groups of CD1 and C57BL/6 mice under study.
Specifically, the baseline weight of the CD1 mice was 31.660.34 g
(n=64) and that of C57BL/6 mice 19.160.10 g (n=64), which is
typical of these strains. Treatment with LPS reduced the body
weight of CD1 (Figure 2A) and C57BL/6 (Figure 3A) mice to a
significant extent, while vehicle treatment had no effect. The LPS-
induced decrease in body weight was on average 2.1–2.6 g in CD1
mice and 2.4–2.5 g in C57BL/6 mice (Figures 2A and 3A). In
both strains of mice this weight loss did not significantly differ
between singly housed and group-housed animals (Figures 2A and
3A). The detailed results of the statistical analysis of the data are
reported in Text S1.
LPS had no effect on body weight 28 days
post-treatment
When CD1 and C57BL/6 mice were weighed 28 days post-
treatment, their body weight was higher than immediately before
IP injection of LPS or its vehicle (Figures 2B and 3B). The increase
in body weight amounted on average to 1.0–2.8 g in CD1 mice
and to 1.9–3.4 g in C57BL/6 mice (Figures 2B and 3B) and was
statistically significant in either strain of mice (see Text S1).
However, the weight gain did not significantly differ between
singly housed and group-housed animals and between vehicle- and
LPS-treated mice of either strain (Figures 2B and 3B).
LPS induced short-term depression-like behavior in
group-housed CD1 mice
The behavior in the FST was assessed 1 and 28 days after IP
injection of LPS or its vehicle and analyzed with respect to the
factors time (1 day versus 28 days post-treatment) and treatment
(LPS versus vehicle). Relative to vehicle, LPS failed to alter the
duration of immobility and climbing in singly housed CD1 mice
both 1 day and 4 weeks after treatment (Figure 4A,C). In contrast,
Figure 1. Experimental groups and time lines. In protocol 1, the effect of IP injected vehicle (VEH) and LPS on depression-like behavior in the
FST was assessed 1 and 28 days post-injection. In protocol 2, the depression-related effect of vehicle and LPS was assessed with the sucrose
preference (SP) test during days 21–4 and days 26–27 post-injection.
doi:10.1371/journal.pone.0020719.g001
Figure 2. Effect of LPS (0.83 mg/kg injected IP), relative to
vehicle (VEH), on the body weight of CD1 mice as measured
immediately before and 1 day (A) as well as 28 days (B) after
treatment under single and group housing conditions. The
graphs show the change in weight (weight after treatment minus
weight before treatment). The values are means+SEM, n=8. *** P,0.01
versus change in weight following treatment with vehicle.
doi:10.1371/journal.pone.0020719.g002
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was significantly reduced by LPS (see Text S1), but since there was
no interaction between the factors time and treatment, this effect
of LPS could not be further analyzed (Figure 4B).
The effect of LPS on the FST behavior in group-housed CD1
mice was much more pronounced than in singly housed CD1 mice
(Figure 4). Relative to vehicle, LPS significantly prolonged the
duration of immobility in group-housed CD1 mice 1 day, but not
28 days, post-treatment (Figure 4A). This LPS-induced extension
of immobility was complemented by a highly significant shortening
of the duration of swimming 1 day post-treatment, whereas 28
days post-treatment the effect of LPS to reduce the duration of
swimming in group-housed CD1 mice was clearly less pronounced
but still statistically significant (Figure 4B). In contrast, the
duration of climbing spent by group-housed CD1 mice was not
significantly altered by LPS 1 and 28 days post-treatment
(Figure 4C).
LPS induced short- and long-term depression-like
behavior in C57BL/6 mice
The experiments conducted with C57BL/6 mice were analo-
gous to those carried out with CD1 mice, yet the outcome of the
FST differed substantially between CD1 mice (Figure 4) and
C57BL/6 mice (Figure 5). Two-way ANOVA disclosed an effect
of treatment (LPS versus vehicle) on the duration of immobility,
swimming and climbing (see Text S1). However, since there was
no significant interaction between the factors treatment and time,
the effect of LPS could not be subjected to post-hoc analysis of
group differences. Notwithstanding this fact, LPS prolonged the
duration of immobility in singly housed C57BL/6 mice
(Figure 5A), while at the same time the duration of climbing was
shortened (Figure 5C). In addition, the duration of swimming was
reduced by LPS in a time-dependent manner (Figure 5B). A
synopsis of the data obtained in singly housed C57BL/6 mice
indicates that LPS prolonged the duration of immobility along
with a shortening of the duration of both swimming and climbing,
these changes being numerically more pronounced 1 day than 28
days post-treatment (Figure 5A,B,C).
The effect of LPS on the behavior of group-housed C57BL/6
mice in the FST showed a distinct time course over the 28-day
period post-treatment. Thus, the duration of immobility was
significantly shortened by LPS 1 day, but significantly prolonged
28 days post-treatment (Figure 5A). In addition, the duration of
immobility recorded in vehicle-treated animals 1 day post-
treatment was significantly longer than that recorded 28 days
post-treatment (Figure 5A). The changes in immobility duration
which LPS evoked in group-housed C57BL/6 mice (Figure 5A)
were complemented by alterations in the duration of swimming
(Figure 5B) and climbing (Figure 5C). Specifically, LPS shortened
the duration of swimming in group-housed C57BL/6 mice 28 days
post-treatment, but not 1 day post-treatment (Figure 5B). In
addition, the duration of swimming recorded in vehicle-treated
animals 1 day post-treatment was shorter than that recorded 28
days post-treatment (Figure 5B). The duration of climbing
observed in group-housed C57BL/6 mice was significantly
prolonged by LPS 1 day, but not 28 days, after treatment
(Figure 5C). Taken all aspects together, it is evident that in group-
housed C57BL/6 mice LPS shortened immobility 1 day post-
treatment due to an increase in climbing, but prolonged
immobility 28 days post-treatment at the expense of swimming
(Figure 5A,B,C).
LPS caused short-term, but not long-term, increases in
circulating corticosterone levels
The plasma concentrations of corticosterone were measured
30 min after the FST had begun. Two-way ANOVA of the
corticosterone levels measured in singly housed CD 1 mice
(Figure 6A) revealed an effect of treatment (LPS versus vehicle)
but, since there was no significant interaction between the factors
treatment and time (see Text S1), the effect of LPS could not be
subjected to post-hoc analysis of group differences. Despite this
fact it is evident from Figure 6A that LPS enhanced the post-FST
levels of corticosterone in singly housed CD 1 mice and that this
LPS-induced increase in circulating corticosterone was nominally
more pronounced 1 day post-treatment than 28 days post-
treatment (Figure 6A). A similar result was obtained in group-
housed CD1 mice (see Text S1) in which the effect of LPS to
enhance the post-FST plasma corticosterone levels was seen 1 day,
but not 28 days, post-treatment (Figure 6A).
The effect of LPS on the post-FST plasma concentrations of
corticosterone in C57BL/6 mice was analogous to that seen in
Figure 3. Effect of LPS (0.83 mg/kg injected IP), relative to
vehicle (VEH), on the body weight of C57BL/6 mice as
measured immediately before and 1 day (A) as well as 28 days
(B) after treatment under single and group housing conditions.
The graphs show the change in weight (weight after treatment minus
weight before treatment). The values are means+SEM, n=7–8.
*** P,0.01 versus change in weight following treatment with vehicle.
doi:10.1371/journal.pone.0020719.g003
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rise of circulating corticosterone in both singly housed and group-
housed C57BL/6 mice, an effect that was no longer observed 28
days post-treatment (Figure 6B). In addition, the post-FST plasma
levels of corticosterone measured 28 days after vehicle treatment of
singly housed and group-housed C57BL/6 mice were significantly
lower than 1 day after vehicle treatment (Figure 6B).
Additional analysis revealed that the post-FST plasma concen-
trations of corticosterone depended on the housing conditions.
Thus, the circulating levels of the glucocorticoid measured 28 days
after vehicle/LPS treatment of singly housed CD1 and C67BL/6
mice were lower than those in the respective group-housed
animals (Figure 6A,B).
The effect of LPS to transiently increase circulating
interleukin-6 levels was more pronounced in C57BL/6
mice than in CD1 mice
The plasma levels of interleukin-6 were measured 30 min after
the FST had begun. Relative to vehicle, LPS increased the
circulating concentrations of interleukin-6 1 day, but not 28 days,
after treatment of singly housed and group-housed CD1 mice
(Figure 7A). C57BL/6 mice turned out to be particularly sensitive
Figure 5. Effect of LPS (0.83 mg/kg injected IP), relative to vehicle (VEH), on the behavior of C57BL/6 mice in the FST as recorded 1
and 28 days after treatment under single and group housing conditions. The graphs show (A) the duration of immobility, (B) the duration
of swimming, and (C) the duration of climbing, these parameters being expressed as a percentage of the total test duration. The values are
means+SEM, n=8. ** P,0.05, *** P,0.01 versus vehicle-treated mice at the same time point post-treatment, ++ P,0.05, +++ P,0.01 versus vehicle-
treated mice tested 28 days post-treatment. In panels A (Single), B (Single) and C (Single) it was not possible to apply a post-hoc test because two-
way ANOVA failed to disclose any interaction between the factors time and treatment.
doi:10.1371/journal.pone.0020719.g005
Figure 4. Effect of LPS (0.83 mg/kg injected IP), relative to vehicle (VEH), on the behavior of CD1 mice in the FST as recorded 1 and
28 days after treatment under single and group housing conditions. The graphs show (A) the duration of immobility, (B) the duration of
swimming, and (C) the duration of climbing, these parameters being expressed as a percentage of the total test duration. The values are means+SEM,
n=8. * P#0.1, *** P,0.01 versus vehicle-treated mice at the same time point post-treatment. In panel B (Single) it was not possible to apply a post-
hoc test because two-way ANOVA failed to disclose any interaction between the factors time and treatment.
doi:10.1371/journal.pone.0020719.g004
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of interleukin-6 measured 1 day after LPS treatment were much
higher than in CD1 mice (Figure 7A,B). While, in CD1 mice, LPS
enhanced the plasma concentrations of interleukin-6 on average
by factors of 7.2–12.1, it increased circulating interleukin-6 in
C57BL/6 mice on average by factors of 20.2–30.5 (Figure 7A,B).
Much as in CD1 mice, however, the effect of LPS had waned 28
days after treatment of singly housed and group-housed C57BL/6
mice (Figure 7B). In neither strain of mice did the interleukin-6
concentrations significantly differ between singly housed and
group-housed animals.
LPS caused a long-term inhibition of sucrose preference
in C57BL/6 mice
The effect of LPS on sucrose preference and total water intake
was investigated in singly housed C57BL/6 mice for a period of 27
days. As expected, the animals strongly preferred sucrose (1%)
solution over normal tap water (Figure 8A,B). Following injection
of vehicle or LPS, there was a change in their drinking behavior.
Vehicle treatment transiently increased the consumption of water
and slightly decreased the intake of sucrose solution during the 24-
h period post-treatment (Figure 8A). Planned comparison of the
relative contribution of sucrose solution and water intake to the
total consumption of fluid revealed that on day 26 after vehicle
treatment the relative intake of sucrose solution and water was
indistinguishable from that measured during the day before
vehicle treatment (Figure 8A, insert). Both on day 1 before (day -1)
and on day 26 after vehicle treatment, the intake of sucrose
solution covered more than 80% of the total consumption of fluid
(Figure 8A, insert).
In contrast to vehicle, LPS led to a short-term reversal of sucrose
preference to water preference. As is shown in Figure 8B, the
intake of sucrose solution was reduced by more than 70% during
the 24-h period after LPS treatment, while the consumption of
water was enhanced. The relative consumption of sucrose solution
versus water normalized over the following days, but on days 26
and 27 post-treatment the relative intake of sucrose solution was
nominally lower, and that of water nominally higher, than before
LPS treatment (Figure 8B). This instance was also revealed by
planned comparison of the relative contribution of sucrose solution
and water intake to the total consumption of fluid (Figure 8B,
insert). While on day 1 before LPS treatment (day -1) the intake of
sucrose solution covered some 80% of the total consumption of
fluid, the relative intake of sucrose solution and water was no
longer significantly different from each other on day 26 after LPS
treatment (Figure 8B, insert).
Further analysis demonstrated that the total intake of fluid
significantly increased during day 1 after vehicle treatment but
otherwise stayed constant during the 26-day observation period
post-treatment (Figure 9). In contrast, the total consumption of
fluid did not significantly change during the 26-day observation
period after LPS treatment, but during days 1 and 2 post-
treatment was significantly lower than after vehicle treatment
(Figure 9).
Discussion
Behavioral analysis of female mice
The present data show that a single IP injection of LPS is able to
induce long-term depression-like behavior in mice, an effect that
depends on genetic background (strain) and, in part, on social
environment. The dose of LPS used here (0.83 mg/kg) was
identical to that used previously in the examination of its impact
on depression-like behavior [12,14]. The current study was carried
out with female mice because affective disorders are more
prevalent in women than in men [17], a situation that need be
reflected in the design of translational animal experiments [18].
We did not monitor the estrous cycle in order to avoid additional
stress which may influence the behavior of the animals. On the
one hand, stress can prolong the estrous cycle [30] while, on the
Figure 6. Effect of LPS (0.83 mg/kg injected IP), relative to
vehicle (VEH), on plasma concentrations of corticosterone as
recorded 1 and 28 days after treatment under single and
group housing conditions. Trunk blood of CD1 (A) and C57BL/6 (B)
mice for the corticosterone assay was taken 30 min after the FST had
been started. The values are means+SEM, n=7–8. *** P,0.01 versus
vehicle-treated mice at the same time point post-treatment, + P#0.1,
+++ P,0.01 versus vehicle-treated mice tested 1 day post-treatment. In
panel A it was not possible to apply a post-hoc test because two-way
ANOVA failed to disclose any interaction between the factors time and
treatment.
doi:10.1371/journal.pone.0020719.g006
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endotoxin [31], depression-like behavior [32,33] and circulating
corticosterone [34]. Although being aware of these limitations, we
consider it unlikely for a number of reasons that our data were
significantly confounded by these factors. First, the experiments
were carried out in the strict absence of male mice. Second, we
have previously found that the estrous cycle is largely synchronized
within the same and across different cages [35]. Third, the effects
of LPS and its vehicle were examined in parallel under identical
housing conditions. Fourth, the coefficient of variation of the data
obtained in female mice did not appear anomalous in comparison
to data obtained in male mice [36].
Short-term behavioral effects of LPS
The short-term effect of LPS on behavior in the FST was
evaluated because it may be of relevance to its long-term effect. It
has previously been shown that singly housed male CD1 mice
exhibit enhanced depression-like behavior in the FST 24 h post-
LPS, as revealed by an increase in the immobility time at the
expense of swimming time [12]. In the current study with female
CD1 mice, an increase in depression-related behavior 1 day post-
LPS was seen only under group housing conditions. In C57BL/6
mice, to the contrary, depression-like behavior was markedly
enhanced by LPS only under single housing conditions. In
addition, the behavioral profile of the depressogenic effect of LPS
in C57BL/6 mice (prolonged immobility time, shortened swim-
ming and climbing time) differed from that of CD1 mice
(prolonged immobility time, shortened swimming time). The
finding that, in group-housed C57BL/6 mice, LPS reduced
immobility and enhanced climbing could be related to the
apparent ability of vehicle to increase immobility and decrease
climbing.
In interpreting these diverse observations made 1 day post-
treatment several factors need be considered. First, the acute effect
of LPS on behavior in the FST may rather be related to the
transient sickness response, which can last for up to 2 days [37],
than reflect a truly depressogenic effect [37]. Second, affective
behavior in group-housed animals may be influenced by strain-
related empathy among the cage mates [38–40] under the distress
caused by LPS. Third, social isolation of mice can, on the one
hand, increase the LPS-evoked sickness behavior [22] and, on the
other hand, enhance depression-like behavior [25,41–43]. Thus,
the acute effect of LPS on the behavior in the FST under different
housing conditions is a function of multiple interactive factors.
Long-term depression induced by LPS
The major advance put forward by the present study is the
discovery that LPS is able to induce long-term depression-like
behavior in a strain-related manner. While the acutely depresso-
genic effect of LPS in group-housed CD1 mice had largely waned
4 weeks post-treatment, long-term depression in C57BL/6 mice
was induced whether or not there was an acutely depressogenic
effect. Importantly, the behavioral profile of the LPS-evoked long-
term depression in group-housed C57BL/6 mice (prolonged
immobility time, shortened swimming time) differed from that in
singly housed C57BL/6 mice (prolonged immobility time,
shortened climbing time).
The profile of the LPS-induced behavioral changes in the FST
is worth noting because antidepressants that enforce serotonergic
transmission increase primarily swimming behavior, while antide-
pressants that enhance noradrenergic transmission increase
predominantly climbing behavior [15,43]. In analogy, there is
reason to speculate that the long-term depression-like behavior
caused by LPS in group-housed C57BL/6 mice involves
serotonergic but not noradrenergic pathways, while the depres-
sion-like behavior induced by LPS in singly housed C57BL/6 mice
depends on noradrenergic but not serotonergic circuits. It would
hence appear that the neurochemical substrates whereby LPS
alters depression-like behavior in the FST differ with housing
conditions. This instance provides a lead for targeted studies into
Figure 7. Effect of LPS (0.83 mg/kg injected IP), relative to vehicle (VEH), on plasma concentrations of interleukin-6 as recorded 1
and 28 days after treatment under single and group housing conditions. Trunk blood of CD1 (A) and C57BL/6 (B) mice for the interleukin-6
assay was taken 30 min after the FST had been started. The values are means+SEM, n=7–8. ** P,0.05, *** P,0.01 versus vehicle-treated mice at the
same time point post-treatment.
doi:10.1371/journal.pone.0020719.g007
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disturbances of affective behavior. The studies need to take
account of particular characteristics of monoaminergic transmis-
sion in the brain of C57BL/6 mice. While C57BL/6 mice, like
CD1 mice, are sensitive to the antidepressant effect of desipra-
mine, a preferential norepinephrine reuptake inhibitor, in the FST
[44], the serotonin transporter of C57BL/6 mice contains 2 non-
synonymous single nucleotide polymorphisms that code for a
reduced reuptake function and a reduced immobility time in the
tail suspension test [16].
The prolonged depression-like behavior in LPS-treated
C57BL/6 mice as observed in the FST was confirmed with the
sucrose preference test in an independent cohort of animals. The
two tests address different aspects of depression. While the FST
measures behavioral despair [15], the sucrose preference test
assesses anhedonia, a decrease in the ability to experience pleasure
[12,45,46]. LPS exerted two distinct time-related effects on sucrose
preference in singly housed C57BL/6 mice. One day post-
treatment, there was a pronounced reduction of sucrose
preference, an effect that waned during the subsequent days and
had previously been noted in CD1 mice [12]. Twenty-six days
post-treatment, however, the sucrose preference was found to be
attenuated in LPS-treated C57BL/6 mice, which attests to a long-
term effect of LPS to induce anhedonia-like behavior.
Short-term and long-term effects of LPS on circulating
interleukin-6 and corticosterone
The LPS-induced changes in body weight did not provide any
explanation for its strain-dependent impact on affective behavior
in the short and long term. The initial decrease in body weight is
part of the transient ‘‘sickness response’’ to LPS, which includes
anorexia and a reduction of locomotion and exploration
[3,6,11,47]. The sickness response arises from LPS-evoked
induction of proinflammatory cytokines, including interleukin-6,
that signal to the brain via a neural and endocrine route [6,11,22].
Our finding that LPS increased the post-FST plasma levels of
interleukin-6 1 day but not 4 weeks post-treatment indicates that
LPS, but not the FST, was responsible for the rise of this cytokine.
The observation that circulating interleukin-6 in C57BL/6 mice
increased to a much larger extent than in CD1 mice suggests that
C57BL/6 mice are more sensitive to immune stress than CD1
mice. It remains to be shown whether the pronounced induction of
interleukin-6 in C57BL/6 mice has any bearing on the long-term
depression-like behavior induced by LPS in this mouse strain.
LPS and proinflammatory cytokines are able to stimulate the HPA
axis as shown by a rise of circulating glucocorticoid levels [4–6,22]. In
the present study, the plasma levels of corticosterone measured
30 min post-FST do not represent basal levels of the glucocorticoid
but reflect levels that are elevated by the stress of the FST procedure
[36]. Single housing is stressful for female mice [48] and results in a
reduction of the basal levels of circulating corticosterone [25].
Likewise, the post-FST levels of corticosterone measured 28 days
after vehicle/LPS treatment were lower under single housing than
under group housing conditions. We do not think, however, that the
LPS-evoked long-term depression-like behavior in C57BL/6 mice
arises primarily from a change in the function of the HPA axis,
although two distinct alterations in the dynamics of the HPA axis
were observed. First, LPS enhanced the FST-evoked increase in
circulating corticosterone 1 day post-treatment independently of
strain and housing conditions, whereas 4 weeks post-treatment this
effect of LPS was largely gone. This observation is in keeping with the
contention that the HPA axis undergoes prolonged desensitization
after immune challenge [49]. Second, the post-FST plasma levels of
corticosterone measured in C57BL/6 mice 28 days post-treatment
were in general significantly lower than 1 day post-treatment. This
observation may reflect a particular trait of C57BL/6 mice to
respond to experimental interventions by a long-term change inHPA
axis dynamics.Elucidationof the full impact of the HPAaxis on LPS-
evoked long-term changes in affective behavior willinvolve analysis of
basal and stress-related levels of corticosterone and of the time course
of the HPA axis response to stress.
Conclusion
The current study demonstrates that immune challenge with
LPS is able to induce prolonged depression-like behavior.
Importantly, this effect depends on genetic background (strain).
It has been noted before that the impact of immune challenge on
affective behavior need be analyzed with respect to background
conditions [22]. The availability of an experimental model of long-
term depression-like behavior after acute immune challenge will
aid the elucidation of the pathophysiology of immune system-
related affective disorders and of the epigenome that is controlled
by social environment and immune system activity [50].
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Figure 9. Effect of vehicle (VEH) and LPS (0.83 mg/kg injected
IP) on the total daily intake of fluid in singly housed C57BL/6
mice. The graph shows the absolute daily intake of fluid on the day
before treatment (day -1) and on days 1, 2 and 26 post-treatment. The
values are means+SEM, n=7. ** P,0.05, *** P,0.01 versus vehicle on
the same day, +++ P,0.01 versus vehicle on all other days.
doi:10.1371/journal.pone.0020719.g009
Figure 8. Effect of (A) vehicle (VEH) and (B) LPS (0.83 mg/kg injected IP) on the daily consumption of sucrose (1%) solution and
normal tap water in singly housed C57BL/6 mice. The main graphs show the absolute daily intake of sucrose solution and water (ml). In the
inserts, the daily intake of sucrose solution and water on the day before treatment (day -1) and on day 26 post-treatment is expressed as a percentage
of the total daily fluid intake. The values are means6SEM, n=7. *** P,0.01 versus water intake.
doi:10.1371/journal.pone.0020719.g008
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